Skip to main content

Table 1 Demographics and clinicopathologic characteristics of patients with glioma

From: ARL3 is downregulated and acts as a prognostic biomarker in glioma

Characteristic Primary cohort Validation cohort
CGGA (n = 310) Gravendeel (n = 211) TCGA (n = 598)
No. of patients % No. of patients % No. of patients %
ARL3 level
 Median 13.402   6.658   10.623  
 Range 2.762–28.522   5.591–8.921   8.787–13.299  
Gender
 Male 195 62.903 146 69.194 350 58.528
 Female 115 37.097 65 30.806 248 41.472
Age, years
 Median 43   50   47  
 Range 8–81   14–81   14–89  
WHO grade
 Grade II 105 33.871 21 9.953 211 35.284
 Grade III 67 21.613 66 31.280 239 39.967
 Grade IV 138 44.516 124 58.768 148 24.749
IDH status
 Wild type 146 47.097 131 62.085 222 37.124
 Mutant 164 52.903 80 37.915 376 62.876
\